Effects of DNA adduct structure and distribution on the mutagenicity and genotoxicity of two platinum anticancer drugs.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Molecular Biology

• Publication date

  1994-03-04

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0022-2836(94)90010-8PMID 8120885
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutagenicity and genotoxicity of the major DNA adduct of the antitumor drug cis-diamminedichloroplatinum(II).

  1993cited by this paper
• Literature highlights—29

  1992cited by this paper
• DNA binding properties of [Pt(NH3)(C6H11NH2)Cl2], a metabolite of an orally active platinum anticancer drug

  1992cited by this paper
• Mutations recovered in the Chinese hamster aprt gene after exposure to carboplatin: a comparison with cisplatin.

  1992cited by this paper
• Is cisplatin a human carcinogen?

  1992cited by this paper
• Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts.

  1992cited by this paper
• Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines.

  1992cited by this paper
• The use of Taq DNA polymerase to determine the sequence specificity of DNA damage caused by cis-diamminedichloroplatinum(II), acridine-tethered platinum(II) diammine complexes or two analogues.

  1992cited by this paper
• Spectrum of cis‐diamminedichloroplatinum(II)‐induced mutations in a shuttle vector propagated in human cells

  1991cited by this paper
• A sensitive method for the detection of beta-galactosidase in transfected mammalian cells.

  1991cited by this paper
• A sensitive method for the detection of beta-galactosidase in transfected mammalian cells.

  1991cited by this paper
• Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replication.

  1990cited by this paper
• Single d(ApG)/cis-diamminedichloroplatinum(II) adduct-induced mutagenesis in Escherichia coli.

  1990cited by this paper
• Rapid reduction of tetrachloro(D,L-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in RPMI 1640 tissue culture medium.

  1989cited by this paper
• Sequence specificity of mutation induced by the anti-tumor drug cisplatin in the CHO aprt gene.

  1989cited by this paper
• Imaging plate illuminates many fields

  1988cited by this paper
• Specificity of mutagenesis by 4-aminobiphenyl. A possible role for N-(deoxyadenosin-8-yl)-4-aminobiphenyl as a premutational lesion.

  1988cited by this paper
• Singlet oxygen‐induced mutations in M13 lacZ phage DNA.

  1987cited by this paper
• Glutathione-mediated activation of anticancer platinum(IV) complexes.

  1987cited by this paper
• Reaction products from platinum(IV) amine compounds and 5'-GMP are mainly bis(5'-GMP)platinum(II) amine adducts.

  1986cited by this paper
• DNA cloning : a practical approach

  1985cited by this paper
• Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum (II).

  1985cited by this paper
• In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein cross-linking, and inhibition of replication.

  1985cited by this paper
• Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.

  1985cited by this paper
• Repair of cis-platinum-DNA adducts by ABC excinuclease in vivo and in vitro

  1985cited by this paper
• Interaction of the antitumor agents cis,cis,trans-PtIV(NH3)2Cl2(OH)2 and cis,cis,trans-PtIV[(CH3)2CHNH2]2Cl2(OH)2 and their reduction products with PM2 DNA.

  1984cited by this paper
• Mutational specificity of depurination.

  1984cited by this paper
• Sequence analysis of ultraviolet-induced mutations in M13lacZ hybrid phage DNA.

  1984cited by this paper
• [2] New M13 vectors for cloning

  1983cited by this paper
• New M13 vectors for cloning.

  1983cited by this paper
• Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II).

  1983cited by this paper
• Mechanism of toxicity of platinum(II) compounds in repair-deficient strains of Escherichia coli

  1982cited by this paper
• Influence of temperature on platinum binding to DNA, cell killing, and mutation induction in Escherichia coli K-12 cells treated with cis-diamminedichloroplatinum(II).

  1982cited by this paper
• Alteration of plasmid DNA-mediated transformation and mutation induced by covalent binding of benzo[alpha]pyrene-7,8-dihydrodiol-9,10-oxide in Escherichia coli.

  1981cited by this paper
• Base-pair substitution hotspots in GAG and GCG nucleotide sequences in Escherichia coli K-12 induced by cis-diamminedichloroplatinum (II).

  1981cited by this paper
• Efficiency of Escherichia coli repair processes on uv-damaged transforming plasmid DNA.

  1981cited by this paper
• Mutagenicity, cytotoxicity, and DNA binding of platinum(II)-chloroammines in Chinese hamster ovary cells.

  1980cited by this paper
• Mutagenic activity of anticancer agent cis-dichlorodiammine platinum-II.

  1979cited by this paper
• Carcinogenicity of antitumor cis-platinum(II) coordination complexes in the mouse and rat.

  1979cited by this paper
• Platinum complexes: probes of polynucleotide structure and antitumor drugs

  1978cited by this paper
• Mutagenicity of cancer chemotherapeutic agents in the Salmonella/microsome test.

  1977cited by this paper
• DNA sequencing with chain-terminating inhibitors.

  1977cited by this paper
• Mutagenic properties of cis-plantinum(II)diammino-dichloride in Escherichia coli.

  1975cited by this paper
• The chemistry of platinum and palladium : with particular reference to complexes of the elements

  1973cited by this paper
• RNA synthesis initiates in vitro conversion of M13 DNA to its replicative form.

  1972cited by this paper

• Platinum complexes containing adenine-based ligands: An overview of selected structural features

  2017cites this paper
• MutY-glycosylase: an overview on mutagenesis and activities beyond the GO system.

  2014cites this paper
• A role for Myh1 in DNA repair after treatment with strand‐breaking and crosslinking chemotherapeutic agents

  2013cites this paper
• Genotoxicity of metal ions: chemical insights.

  2010cites this paper
• Biological properties of single chemical-DNA adducts: a twenty year perspective.

  2008cites this paper
• Signalisation moléculaire par le système de réparation des mésappariements de l'ADN et l'agent anticancéreux cisplatine : étude des interactions protéine MutS-composé de lésion du cisplatine

  2007cites this paper
• Mutation Spectra in Cisplatin- and Transplatin-treated GDL1 Cells Clarified the Different Mode of Action of These Compounds in Mammalian Cells

  2007cites this paper
• Title Page hREV 1 Modulates the Cytotoxicity and Mutagenicity of Cisplatin in Human Ovarian Carcinoma Cells

  2006cites this paper
• hREV1 Modulates the Cytotoxicity and Mutagenicity of Cisplatin in Human Ovarian Carcinoma Cells

  2006cites this paper
• Human REV 1 Modulates the Cytotoxicity and Mutagenicity of Cisplatin in Human Ovarian Carcinoma Cells

  2006cites this paper
• DNA Polymerase ζ Accounts for the Reduced Cytotoxicity and Enhanced Mutagenicity of Cisplatin in Human Colon Carcinoma Cells That Have Lost DNA Mismatch Repair

  2006cites this paper
• Human REV1 Modulates the Cytotoxicity and Mutagenicity of Cisplatin in Human Ovarian Carcinoma Cells

  2006cites this paper
• A combination of access to preassociation sites and local accumulation tendency in the direct vicinity of G-N7 controls the rate of platination of single-stranded DNA.

  2005cites this paper
• Suppression of hREV1 Expression Reduces the Rate at Which Human Ovarian Carcinoma Cells Acquire Resistance to Cisplatin

  2005cites this paper
• DNA Polymerase ζ Regulates Cisplatin Cytotoxicity, Mutagenicity, and The Rate of Development of Cisplatin Resistance

  2004cites this paper
• Activation barriers and rate constants for hydration of platinum and palladium square-planar complexes: an ab initio study.

  2004cites this paper
• Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome.

  2003cites this paper
• Mécanisme d'action de la drogue anticancéreuse cis-dichlorodiammineplatine (II) : étude de l'interaction entre les protéines de réparation des mésappariements et l'ADN platiné

  2003cites this paper
• Binding Discrimination of MutS to a Set of Lesions and Compound Lesions (Base Damage and Mismatch) Reveals Its Potential Role as a Cisplatin-damaged DNA Sensing Protein*

  2003cites this paper
• Genotoxic Action of Cycloplatam, a New Platinum Antitumor Drug, on Mammalian Cells in vivo and in vitro

  2003cites this paper
• Chromium(III) tris(picolinate) is mutagenic at the hypoxanthine (guanine) phosphoribosyltransferase locus in Chinese hamster ovary cells.

  2002cites this paper
• Mutagenic activity of cisplatin in the lacZ plasmid‐based transgenic mouse model

  2002influential citation
• Characterization of the mutational specificity of DNA cross-linking mutagens by the Lac+ reversion assay with Escherichia coli.

  2001cites this paper
• Non-uniform rate for platination of guanine-N7 located in short DNA oligomers

  2001cites this paper
• Mutagenic Effects of Cisplatin the Sensitivity of Human Colon Cancer Cells to the Cytotoxic p 53 Modulates the Effect of Loss of DNA Mismatch Repair on Updated

  2001cites this paper
• Anticlastogenic effect of Vitamin C on cisplatin induced chromosome aberrations in human lymphocyte cultures.

  2001cites this paper
• Prospects for applying genotypic selection of somatic oncomutation to chemical risk assessment.

  2001cites this paper
• Modulates the Effect of Loss of DNA Mismatch Repair on the Sensitivity of Human Colon Cancer Cells to the Cytotoxic and Mutagenic Effects of Cisplatin 1

  2001cites this paper
• Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis.

  2001cites this paper
• P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin.

  2001cites this paper
• Cytogenetic Toxicity of Cisplatin in Bone Marrow Cells of Swiss Mice

  2000cites this paper
• Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts.

  1999cites this paper
• Specificity of platinum-DNA adduct repair.

  1999cites this paper
• Effect of loss of DNA mismatch repair on development of topotecan-, gemcitabine-, and paclitaxel-resistant variants after exposure to cisplatin.

  1999cites this paper
• The role of DNA mismatch repair in cisplatin mutagenicity.

  1999cites this paper
• Effects of cis-diamminedichloroplatinum(II) on Escherichia coli and bacteriophage systems.

  1998cites this paper
• STUDIES ON THE CHROMOSOMES OF MURINE DALTON'S LYMPHOMA CELLS AND THE EFFECT OF CISPLATIN ON CHROMOSOMES OF THESE CELLS AND BONE MARROW CELLS IN VIVO

  1998cites this paper
• Correlation between Sequence-dependent Glycosylase Repair and the Thermal Stability of Oligonucleotide Duplexes Containing 1,N 6-Ethenoadenine*

  1998cites this paper
• Kinetics of interaction of the thione unit in 4-thio-2′-deoxyuridine and 4-thiouridine 5′-monophosphate with rapidly reacting gold(III) complexes‡

  1998cites this paper
• An Efficient Synthesis of a Furan-Side Furocoumarin Thymidine Monoadduct.

  1997cites this paper
• Transplacental mutagenicity of cisplatin: H-ras codon 12 and 13 mutations in skin tumors of SENCAR mice.

  1996cites this paper
• Mutagenic and carcinogenic properties of platinum-based anticancer drugs.

  1996cites this paper
• A comparison of the genotoxic effects of carboplatin and cisplatin in Escherichia coli.

  1996cites this paper
• Effect of quercetin on the genotoxic potential of cisplatin

  1996cites this paper
• Fork-like DNA templates support bypass replication of lesions that block DNA synthesis on single-stranded templates.

  1996cites this paper
• Mutational and DNA Binding Specificity of the Carcinogen 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline*

  1996cites this paper
• Mutagenesis by the primary aflatoxin B₁ DNA adduct in Escherichia coli

  1996cites this paper
• Electrospray ionization mass spectrometry of covalent ligand-oligonucleotide adducts: evidence for specific duplex ion formation.

  1995cites this paper
• Anticancer drugs: an underestimated risk or an underutilised resource in mutagenesis?

  1995cites this paper
• Molecular and Cellular Aspects of Chemical Carcinogenesis

  1995cites this paper
• Comparative Toxicities and Mutagenicities of Platinum Anticancer Drugs*

  1995cites this paper
• Mutagenic and genotoxic effects of DNA adducts formed by the anticancer drug cis-diamminedichloroplatinum(II).

  1995cites this paper